All times listed are PT

8:30-9:00 am

Registration
Li Ka Shing Center, Paul & Mildred Berg Hall
291 Campus Drive, Stanford

Joseph Wu, MD, PhD
Director, Stanford Cardiovascular Institute; Simon H. Stertzer, MD, Professor of Medicine and Radiology, Stanford University School of Medicine

Lloyd Minor, MD
Carl and Elizabeth Naumann Professorship for the Dean, Stanford University School of Medicine

Flavius Martin, MD
Executive Vice President of Research, Gilead Sciences
Research at Gilead: Success Through Synergy

Robert Plenge, MD, PhD
Executive Vice President, Chief Research Officer, Head of Research, Bristol Myers Squibb
Improving R&D Productivity for Cardiovascular Medicines

Michael Devoy, MD
Chief Medical Officer and Executive Vice President of Medical Affairs and Pharmacovigilance for the Pharmaceuticals Division, Bayer
Towards Precision Medicine Through Cell and Gene Therapy: Considerations for Discovery, Development, and Healthcare Implementation

Aida Habtezion, MD
Chief Medical Officer and Head of Worldwide Medical and Safety, Pfizer
AI and Machine Learning Across Pfizer’s Research and Development

Sharon Barr, PhD
Executive Vice President, BioPharmaceuticals R&D, AstraZeneca
Driving Patient Centric Drug Discovery

Panel Discussion

11:00-12:30 pm

Networking Lunch
Alumni Lawn in front of Li Ka Shing Center

Robert Califf, MD
Commissioner, U.S. Food and Drug Administration

Marianne De Backer, MSc, PhD, MBA
Chief Executive Officer and Director, Vir Biotechnology

Michelle Longmire, MD
Chief Executive Officer, Co-Founder, Medable

Daniel Skovronsky, MD, PhD
Chief Scientific Officer and President, Lilly Research Laboratories; President, Immunology, Eli Lilly and Company

Bei Zhang, PhD
Corporate Vice President & TA Head, Diabetes, Obesity, & MASH (DO&M), Global Drug Discovery, Novo Nordisk

Michelle Williams, ScD
Joan and Julius Jacobson Professor of Epidemiology and Public Health, Harvard T.H. Chan School of Public Health

1:45-2:10 pm

Coffee Break

Grace Han McMahon, JD, MBA
Associate Vice President and Head, Pacific Hub, Business Development & Licensing, Merck

Paul Biondi, MBA
Executive Partner and President of Pioneering Medicines, Flagship Pioneering

Andrea van Elsas, PhD
Partner, Third Rock Ventures

Joe Jimenez, MBA
Co-Founder and Managing Director, Aditum Bio

Introduction:
Joseph Wu, MD, PhD
Director, Stanford Cardiovascular Institute; Simon H. Stertzer, MD, Professor of Medicine and Radiology, Stanford University School of Medicine

Awardee Lecture:
Catherine Boileau, PhD, PharmD
Emeritus Professor of Genetics, Medical School of Paris Cité University
Inserm UMR1148 LVTS Research Center, Bichat University Hospital
PCSK9: from Genetic Heterogeneity of Familial Hypercholesterolemia to Paradigm Shifts

Awardee Lecture:
Helen Hobbs, MD
Philip O’Bryan Montgomery Jr., MD, Distinguished Chair in Developmental Biology; Eugene McDermott Distinguished Chair for the Study of Human Growth and Development, UT Southwestern Medical Center
PCSK9: From Nature's Loss to Patient's Gain

Moderated Q&A Session

Joseph Wu, MD, PhD
Director, Stanford Cardiovascular Institute; Simon H. Stertzer, MD, Professor of Medicine and Radiology, Stanford University School of Medicine

4:05-5:00 pm

Wine and Cheese Networking Reception
Li Ka Shing Center, Paul & Mildred Berg Hall

6:15 pm

Stanford Drug Discovery Symposium Dinner for Speakers and Moderators
Hosted by Alexandria Real Estate Equities

All times listed are PT

8:30-9:00 am

Registration
Li Ka Shing Center, Paul & Mildred Berg Hall
291 Campus Drive, Stanford

Joseph Wu, MD, PhD
Director, Stanford Cardiovascular Institute; Simon H. Stertzer, MD, Professor of Medicine and Radiology, Stanford University School of Medicine

Don Cleveland, PhD
Department Chair, Cellular and Molecular Medicine (CMM); Professor, Cellular and Molecular Medicine, University of California San Diego
Designer DNA Drug Therapy for Neurodegenerative Disease

Gregory Verdine, PhD
Erving Professor of Chemistry, Harvard University
Toward Universal Druggability

Thomas Lynch, MD
President and Director, Fred Hutchinson Cancer Center
Drug Discovery at Fred Hutch Cancer Center

Panel Discussion

10:15-10:40 am

Coffee Break

Abhishek Shukla, MBA
Manager Director, Prosperities7 Ventures

Julie Grant, MBA, MPhil
General Partner, Canaan Partners

Deep Nishar, MBA
Managing Director, General Catalyst

Hallie Kuhn, PhD
Senior Vice President, Alexandria Venture Investments

11:25-12:45

Networking Lunch
Alumni Lawn in front of Li Ka Shing Center

George Addona, PhD
Senior Vice President and Head, Discovery, Preclinical Development, and Translational Medicine, Merck Research Laboratories
Discovery of an Orally Bioavailable Macrocyclic PCSK9 Inhibitor

Paul Burton, MD, PhD
Senior Vice President and Chief Medical Officer, Amgen
Data & Patients: Novel Partners in Drug Development

Andrew Trister, MD, PhD
Chief Medical Officer and Chief Scientific Officer, Verily Life Sciences
Plaiting The Golden Braid: Incorporating Patient-Generated Data In Clinical Development

Paulo Fontoura, MD, PhD
Global Head and Senior Vice President of Neuroscience, Immunology, Ophthalmology, and Rare Diseases, Roche
Future Advances in the Treatment of Neuromuscular Disorders

Panel Discussion

2:10-2:35 pm

Coffee Break

Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research, Food and Drug Administration
Delivering on the Promise of Genetic Medicines

Patrizia Cavazzoni, MD
Director, Center for Drug Evaluation and Research, Food and Drug Administration
Advances and Innovations in CDER’s Approach to Drug Development

Rosa Canet-Avilés, PhD
Vice President, Scientific Programs & Education, California Institute for Regenerative Medicine
Update on CIRM Funding Programs

Joni Rutter, PhD
Director, National Center for Advancing Translational Sciences, National Institutes of Health
Translational Science: Maximizing the Success of Therapeutic Development

Wade Shen
Director of Proactive Health Office, Advanced Research Projects Agency for Health (ARPA-H)
AI and Drug Discovery @ ARPA-H

Panel Discussion

Joseph Wu, MD, PhD
Director, Stanford Cardiovascular Institute; Simon H. Stertzer, MD, Professor of Medicine and Radiology, Stanford University School of Medicine

4:20-5:30

Networking and Poster Session